Advancing Rare Disease Diagnosis and Drug Development Through Partnership

3:30 PM - 4:25 PM, Tuesday, June 9, 2020 ・ Track Pacific (originally)
Search General Info
Search Education
Search Partnering Companies
The sharing of expertise and capabilities between internal R&D teams and external partners plays a vital role in advancing rare disease diagnosis and drug development more quickly, efficiently and effectively ̶ and remains a cornerstone of the industry. In this session, panelists will share their alliance management success stories and lessons learned, discuss the increasing importance of partnership in early science and development, and explore what the future of collaboration in rare disease looks like.
Sponsored By
Executive Vice President, Research and Development
Jazz Pharmaceuticals
President & Chief Executive Officer
Global Blood Therapeutics
New Enterprise Associates (NEA)